Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns

Tuesday, April 16, 2019 - 10:20 in Health & Medicine

The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net